Radiobiological Impact of Acuros XB Dose Calculation Algorithm on Low-Risk Prostate Cancer Treatment Plans Created by RapidArc Technique.
|
|
- Sheila Moody
- 6 years ago
- Views:
Transcription
1 Radiobiological Impact of Acuros XB Dose Calculation Algorithm on Low-Risk Prostate Cancer Treatment Plans Created by RapidArc Technique. 1,2 Suresh Rana, M.S., 2 Kevin Rogers, M.S. 1 Department of Medical Physics, ProCure Proton Therapy Center, 5901 West Memorial Road, Oklahoma City, OK 73142, USA. 2 Department of Radiation Oncology, Arizona Center for Cancer Care, N 83rd Avenue, #127, Peoria, Arizona 85381, USA. ABSTRACT Objective: The purpose of this study was to assess the radiobiological impact of Acuros XB dose calculation algorithm (AXB) on prostate cancer treatment plans created by RapidArc technique. Materials and Methods: A computed tomography (CT) dataset of ten patients with low-risk prostate cancer was selected for this retrospective study. The delineation of prostate, seminal vesicles and organs at risk (OARs) was done on the axial CT images. The treatment plans were created for 6 MV photon beam using RapidArc technique in the Varian Eclipse treatment planning system. The initial dose calculations on treatment plans were performed with Anisotropic Analytical Key words: Acuros XB, Anisotropic Analytical Algorithm, Prostate Cancer, TCP, NTCP, RapidArc.. Algorithm (AAA). Next, AXB plans were created by performing dose re-calculation using AXB for same number of monitor units and identical beam set up as in the corresponding AAA plans. Radiobiological modeling response evaluation was done by calculating Niemierko s Equivalent Uniform Dose (EUD)-based Normal Tissue Complication Probability (NTCP) and Tumor Control Probability (TCP) values. Additionally, the PTV coverage in AXB and AAA plans was evaluated. Results: The averaged TCP values of AAA plan (98.39%) and AXB plans (98.26%) were comparable with difference of 0.14% (P = ). The averaged NTCP values for bladder (P = 0.265) and femur heads (P = 0.281) were well below 0.1 % with no statistical significant differences. However, the averaged NTCP values for the rectum of 0.56 % (AAA) vs % (AXB) suggested the statistical significance (P = ). The PTV coverage in AXB plans was lower by an average 0.89% compared to AAA plans with no statistical significance (P = 0.254). Conclusion: Both the AAA and AXB predicted comparable NTCP and TCP values for low-risk prostate cancer plans created by RapidArc technique. The reduced PTV coverage due to dose re-calculation from AAA to AXB was observed. Corresponding author: Suresh Rana, M.S., Department of Medical Physics, ProCure Proton Therapy Center, 5901 West Memorial Road, Oklahoma City, OK 73142, USA. suresh.rana@gmail.com, Telephone:
2 Suresh Rana INTRODUCTION RapidArc (Varian Medical Systems, Palo Alto, CA) is a volumetric arc therapy (VMAT) technique that delivers modulated radiation beams with simultaneous adjustment of multi-leaf collimator (MLC) field aperture, dose rate and gantry rotation speed. 1, 2 The radiation dose distributions from RapidArc planning are conformal to the tumor while minimizing to the surrounding critical structures. 1, 2 One of the major components that plays a crucial role in the resultant dose distribution and extent of tumor dose heterogeneity is the dose calculation algorithm. 3 Thus, in order to achieve the best therapeutic advantage from RapidArc planning for prostate cancer, media heterogeneities in the photon beam path must be incorporated in the dose calculation algorithm. Moreover, the incident of modulated radiation beams from different directions results in dose heterogeneity within the tumor and small volumes of normal tissues receive doses higher than the prescribed dose. 3 Several authors have investigated the treatment planning for prostate cancer 4, 5, 6, 7, 8, 9 and reported the inconsistent dosimetric results mainly due to the variations found among these studies in terms of target shape, planning target volume (PTV) margins, planning techniques and objectives, beam angles, plan optimization methods and choice of dose calculation algorithm. 4 9 To the best of our knowledge, no previous study has been done on prostate cancer treatment plans investigating the radiobiological impact of commercially available new dose calculation algorithm called Acuros XB algorithm (AXB). Thus, it is important to further investigate how the choice of AXB in RapidArc planning will affect the radiobiological parameters for prostate cancer before using the AXB for real patient treatment cases. The objective of this study was to asses the radiobiological impact of AXB using real computed tomography (CT) data sets of low-risk prostate cancer patients. No comparison between AXB calculations and measurements or Monte Carlo simulations was exploited in this study. However, for the purpose of comparison, the results from prostate cancer treatment plans calculated by Anisotropic Analytical Algorithm (AAA) were used as the standard since AAA is widely tested and validated for radiation dose calculation. Both algorithms (AXB and AAA) are implemented within the Eclipse treatment planning system (TPS) (Varian Medical Systems, Palo Alto, CA). METHODS AND MATERIALS CT Simulation Ten patients with localized prostate cancer underwent through the AnchorMarker-fiducial markers (Biocompatibles, Inc., Oxford, CT) placement performed by the radiation oncologist at our cancer center. Prior to CT simulation, the patients were immobilized in a supine position on a flat tabletop of General Electric LightSpeed CT Scanner using head sponge and vac-lok cushions (CIVCO Medical Solutions, Kalona, Iowa). The CT scans were acquired with pixels at 0.25 cm slice spacing from the top of the iliac crests superiorly to the perineum inferiorly. All the CT images were verified by the radiation oncologist before transferring them via computer network to the Eclipse TPS for subsequent contouring and planning purposes Contouring The clinical target volume (CTV) comprised of prostate and seminal vesicles were contoured by the radiation oncologist on the axial CT slices. The organs at risk (OARs) such as rectum, bladder and femur heads were delineated based on the CT images. The planning target volume (PTV) was generated from the CTV by an isotropic expansion of 5 mm in all directions to compensate for the variability of treatment setup and internal organ motion. A shell-shaped avoidance structure called Ring was created at a distance of 5 mm from the PTV for the plan optimization process in order to achieve the conformal dose plans. Treatment Planning and Optimization Dose Prescription and Dose Constraints The total dose prescribed to the PTV was 79.2 Gy with a daily dose of 1.8 Gy to be treated in 44 fractions, and this treatment regimen was applied for all ten patients in this study. The dose constraints to the OARs summarized in TABLE 1 are based on the recommendation of Radiation Therapy Oncology Group (RTOG)
3 Radiobiological Impact of Acuros XB Dose Calculation Algorithm on... TABLE 1: Dose specification for OARs Normal Organ Limit* D15% D25% D35% D50% Rectum < 75 Gy < 70 Gy < 65 Gy < 60 Gy Bladder < 80 Gy < 75 Gy < 70 Gy <65 Gy Femoral Heads Mean Dose < 45 Gy *Normal organ limit refers to the volume of that organ that should not exceed the dose limit. Abbreviations: OAR = Organ at risk, Dx% = Dose received by X% of total OAR volume, where X % = 15, 25, 35 and 50. Treatment Plan Setup The beam parameters for prostate cancer treatment plans were set up in the Eclipse TPS (version ) using Varian Clinac ix with 120-leaf millennium MLC and 6X mode of 600 MU/min dose rate. All treatment plans were generated using a single coplanar arc and the Beam s-eye-view graphics in Eclipse TPS was used to define the field sizes. The isocenter of each treatment plan was placed at the center of prostate (Figure 1). Treatment Plan Optimization All treatment plans were generated using the volumetric dose optimization method that followed the same systematic strategy in regarding objectives and priorities, which are summarized in TABLE 2. Dose Calculation In this study, the plans computed by AAA and AXB (both include same version ) are referred as AAA and AXB plans respectively. First, initial dose calculation of the optimized plans was performed by AAA. The AAA plans were then normalized such that 100% of the prescribed dose covers the 95% of the PTV (V100 = 95%), and monitor units (MUs) from the normalized AAA plans were recorded. Second, the AXB plans were calculated using the identical beam setup and same number of MUs as in the normalized AAA plans. The dose calculation grid was set to 2.5 mm for all cases. Figure 1: A transversal view of RapidArc plan setup for prostate cancer using single arc technique. 263
4 Suresh Rana Table 2: Parameters used to calculate Niemierko s EUD-based TCP and NTCP Tissue Volume Type 100% dpf #f a γ 50 TD 50 (Gy) TCD 50 (Gy) Dpf(Gy) α/β(gy) Prostate Tumor Rectum Normal Bladder Normal Femur Normal Abbreviations: 100% dpf = 100% dose per fraction; # f =number of fractions; α/β = alpha-beta ratio; and dpf= parameters source data s dose per fraction; EUD = Equivalent Uniform Dose, TCP = Tumor Control Probability, NTCP = Normal Tissue Complication Probability, Femur = Femur Heads Since this study was focused on real clinical usage of AAA and AXB, only brief introduction of dose calculation algorithms are presented. The AXB, first published by Vassiliev et al., 10 solves numerically Linear Boltzmann Transport Equation (LBTE) which describes the macroscopic behavior of radiation particles as they travel through and interact with matter. The AXB is considered to be similar to classic Monte Carlo methods for accurate modeling of dose deposition in heterogeneous media. 10, 11, 12 Since AXB explicitly solves for radiation transport in materials, the by default dose reporting mode in AXB is dose-to-medium (Dm) and we selected Dm for all the AXB calculations in this study. The AAA, first developed by Ulmer et al., 13, 14 and Tillikainen et al. 15, 16 is an analytical photon dose calculation algorithm based on a pencil-beam convolution/superposition technique. The beam model for AAA include separately-modeled contributions from three different photon sources and the tissue heterogeneity is handled by radiologic scaling of primary photons and photon scatter kernel scaling in lateral directions according to local electron density For more detailed descriptions on the AAA and AXB, readers are advised to refer to publications by Tillikainen et al. 15, 16 and Vassilev et al. 10 Radiobiological Modeling For radiobiological model response evaluation, cumulative dose-volume histograms (DVHs) of calculated treatment plans (AAA and AXB) were exported from the Eclipse TPS using dose bins of 40 cgy. The MATLAB and Simulink Student Version -R2012a (The MathWorks, Inc., Natick, Massachusetts) was used for radiobiological modeling analysis. We utilized the MatLab program 17 to calculate the Niemierko s Equivalent Uniform Dose (EUD)-based Normal Tissue Complication Probability (NTCP) and Tumor Control Probability (TCP) values. The Niemierko s phenomenological model was based on the original definition of the EUD that was derived on the basis of a mechanistic formulation using a linear-quadratic (LQ) cell survival model. 17, 18 According to Niemierko s phenomenological model, EUD 17, 19 is defined as a ( ( )) 1 a v i EQD i EUD = i = 1 (1) This model can be used for both tumors and normal tissues. In equation (1), a is a unit less model parameter that is specific to the normal structure or tumor of interest, and vi is unit less and represents the i th partial volume receiving dose D i in Gy. Since the relative volume of the whole structure of interest corresponds to 1, the sum of all partial volumes vi will equal 1 17 Furthermore, in equation (1), EQD 19 is the biologically equivalent physical dose of 2 Gy and defined as: EQD = D α D + β n f α + 2 β (2) 264
5 Radiobiological Impact of Acuros XB Dose Calculation Algorithm on... where, n f and d f = D/n f are the number of fractions and dose per fraction size of the treatment course, respectively. The α/b is the tissue-specific LQ parameter of the organ being exposed 19 Tumor Control Probability Niemierko s EUD-based TCP 17, 19 is defined as TCP = 1 1 γ 50 TCD + 50 EUD (3) where, TCD 50 is the tumor dose to control 50% of the tumors when the tumor is homogeneously irradiated and the g 50 is a unit less model parameter that is specific to the tumor of interest and describes the slope of the dose response curve. 17 Malignant tumor targets generally have large negative values of a. 19, 20 In this study, we chose a = -10 which was reported by Oinam et al. 19 Other EUD-based TCP parameters (Table 3) used in this study are based on the data published by Okunieff et al. 21 For prostate tumor, the alpha/beta value of 1.2 Gy 22 was selected for this study. TABLE 3: Dose-volume constraints and priorities used for optimization of RapidArc prostate plan Structure Objective Volume (%) Dose (cgy) Priority PTV Upper Lower Upper Rectum Upper Upper Upper Upper Bladder Upper Upper Upper Femoral Heads Upper Upper Ring Upper Abbreviations: PTV = Planning Target Volume 265
6 Suresh Rana Normal Tissue Complication Probability Niemierko s EUD-based NTCP 17, 19 is defined as NTCP = 1 1 γ 50 TD + 50 EUD (4) where, TD 50 is the tolerance dose for a 50% complication rate at a specific time interval (e.g., 5 years in the Emami et al. normal tissue tolerance data 23 ) when the whole organ of interest is homogeneously irradiated. The γ 50 is a unit less model parameter that is specific to the normal structure of interest and describes the slope of the dose response curve17, 19, 21 Since parameter a and the Lyman model parameter n are related by a =1/n, 19, 20 the values for a and TD50 were obtained from the Emmai-Burman parameters for NTCP calculations. 24 The same model parameter γ 50 = 4 was used for all OARs. 19 For bladder, Stewart et al. 25 published a high value for the alpha/beta ratio, in the region of 5 to 10 Gy, and we chose to investigate for alpha/beta = 8 Gy. The alpha/beta values for femur heads (0.85) and rectum (3.9) were taking from the studies of Withers et al. 26 and Deore et al. 27 respectively. Statistical Analysis The statistical analysis was done using two-sided student s t-test in a Microsoft Excel spreadsheet, and P value of less than 0.05 (i.e., P < 0.05) was considered to be statistically significant. RESULTS AND DISCUSSION In this radiobiological model response study, we compared two dose calculation algorithms (AAA and AXB) that were used to calculate the dose for low-risk prostate cancer treatment plans created by RapidArc technique. Figure 2 shows the Niemierko s EUD-based TCP value averaged over the ten analyzed patients for AXB and AAA plans. For the localized prostate cancer at Stages T0 and T1, the average TCP values of AAA plans (98.39 ± 0.06 %) and AXB plans (98.26 ± 0.05%) were comparable with average difference of 0.14%. Although the comparison between the TCP values of AAA and AXB plans showed the statistical significance (P = ), the difference (0.14%) between them is unlikely to be clinically significant. Figure 2: The EUD-based average TCP from DVHs of AAA and AXB plans. Abbreviations: EUD = Equivalent Uniform Dose, TCP = Tumor Control Probability, DVH = Dose-Volume Histogram, AAA = Anisotropic Analytical Algorithm, AXB = Acuros XB Algorithm (Values are averaged over the 10 analyzed prostate cancer patients) 266
7 Radiobiological Impact of Acuros XB Dose Calculation Algorithm on... Figure 3: The PTV coverage by 100 % of the prescribed dose of 79.2 Gy in AAA and AXB plans. Abbreviations: PTV = Planning Target Volume, V100 (%) = Percentage of PTV covered by 100% of the prescribed dose, AAA = Anisotropic Analytical Algorithm, AXB = Acuros XB Algorithm. For the purpose of discussion, the percentage of PTV covered by 100% of the prescribed dose (V100) due to dose re-calculation from AAA to AXB was studied. Figure 3 shows the V100 for the ten individual prostate cancer patients in AAA and AXB plans. The averaged V100 of AXB plans (average: 94.15%; range: %) was slightly lower than the V100 of AAA plans (95%). However, the V100 values of AAA and AXB were differed by an average of 0.89%, which is a smaller value compared to its standard deviation (±1.47%), and the difference did not show the statistical significance (P = 0.254). Table 4 summarizes the Niemierko s EUD-based NTCP values averaged over the ten analyzed patients in the AAA and AXB plans. The averaged bladder NTCP values were very small for both the AAA ( %) and AXB ( %), and the difference was not statistically Figure 3: The PTV coverage by 100 % of the prescribed dose of 79.2 Gy in AAA and AXB plans. Abbreviations: PTV = Planning Target Volume, V100 (%) = Percentage of PTV covered by 100% of the prescribed dose, AAA = Anisotropic Analytical Algorithm, AXB = Acuros XB Algorithm. Table 4: EUD-based average NTCP values from DVHs of AAA and AXB plans Organ NCTP AAA AXB (Avg. ± SD) % (Avg. ± SD) % Rectum NTCP 0.56 ± ± Bladder NTCP ± ± Femur NTCP ± ± Abbreviations: EUD = Equivalent Uniform Dose, NTCP = Normal Tissue Complication Probability, DVH = Dose-Volume Histogram, AAA = Anisotropic Analytical Algorithm, AXB = Acuros XB Algorithm; Avg. = Average, SD = Standard Deviation, Femur = Femur Heads * = statistically significant p-value calculated with two-sided Student s t-test (Values are averaged over the 10 analyzed patients) P 267
8 Suresh Rana significant (P = 0.265). Again, for femur heads, the averaged NTCP values of AAA ( %) and AXB ( %) were very low and the difference between their values was not statistically significant (P = 0.281) either. However, the averaged NTCP values for the rectum of 0.56 % (AAA) vs % (AXB) suggested the statistical significance (P = ). In this study, both the AXB and AAA demonstrated comparable TCP and NTCP values; however, the difference between the results of AXB and AAA may become clinically significant for high-risk prostate cancer that generally involves radiation doses to the lymph nodes as well as to the larger volume of tissues with different densities such as pelvic bone, bladder, femur heads and rectum. Thus, the more accurate dose calculation algorithm plays an important role in avoiding the MU miscalculation which will result into dose overestimation or underestimation during the actual patient treatment. It is essential to further investigate the limitations of AXB before using it for real patient treatment cases because the dose underestimation may increase the local disease recurrence, whereas the dose overestimation will likely increase the normal tissue toxicities. The presence of metallic hip prosthesis and its effect on the TCP and NTCP due to dose recalculation from AAA to AXB will be an interesting topic for future studies. Although we could not find the literature to make the direct comparisons against our radiobiological modeling study data for prostate cancer treatment plans created with RapidArc technique, it is relevant to mention two previous radiobiological modeling studies done on prostate cancer. 28, 29 In the study by Vlachaki et al., 28 the averaged TCP values were 99.52% and 97.92% using 3D conformation radiation therapy (3DCRT) and intensity modulation radiation therapy (IMRT) respectively. In the study by Luxton et al., 29 the averaged NTCP values for rectum were 1.7% for IMRT vs. 3.2% for 3DCRT, and these values were later confirmed by Vlachaki et al. 28 By using RapidArc technique in our study, rectum NTCP values were found to be less than 1% for both the AAA and AXB. Both the previous studies 28, 29 reported NTCP values of bladder and femur heads below 0.1%. Similar findings were observed in our study for NTCP values of bladder and femur heads being well below 0.1%. CONCLUSION Both the AAA and AXB predicted comparable NTCP and TCP values for low-risk prostate cancer plans created by RapidArc technique. In comparison to AAA, the AXB produced slightly lower PTV coverage by average 0.89% due to dose recalculation from AAA to AXB. Conflict of Interest: None References 1. Ling CC, Zhang P, Archambault Y, Bocanek J, Tang G, Losasso T. Commissioning and quality assurance of RapidArc radiotherapy delivery system. Int J Radiat Oncol Biol Phys 2008; 72: Tang G, Earl MA, Luan S, Wang C, Mohiuddin MM, Yu CX. Comparing radiation treatments using intensity-modulated beams, multiple arcs, and single arcs. Int J Radiat Oncol Biol Phys 2010; 76: Goitein M, Niemierko A. Intensity modulated therapy and inhomogeneous dose to the tumor: A note of caution Int J Radiat Oncol Biol Phys 1996; 36: Kjaer-Kristoffersen F, Ohlhues L, Medin J, Korreman S. RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol 2009; 48: Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, McKenzie M, Morris J, Otto K. Volumetric modulated arc therapy for delivery of prostate radiotherapy: Comparison with intensitymodulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: Guckenberger M, Richter A, Krieger T, Wilbert J, Baier K, Flentje M. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? Radiother Oncol 2009; 93: Shaffer R, Morris WJ, Moiseenko V, Welsh M, Crumley C, Nakano S, Schmuland M, Pickles T, Otto K. Volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: A planning comparison study. Clin Oncol R Coll Radiol 2009; 21: Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, Herskind C, Polednik M, Steil V, Wenz F, Lohr F. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, stepand-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009; 93: Yoo S, Wu QJ, Lee WR, Yin FF. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes. Int J Radiat Oncol Biol Phys 2010; 76: Vassiliev O, Wareing T, McGhee J, Failla G, Salehpour M, Mourtada F. Validation of a new grid based Blotzmann equation solver for dose calculation in radiotherapy with photon beams. Phys Med Biol 2010; 55: Bush K, Gagne IM, Zavgorodni S, Ansbacher W, Beckham W. Dosimetric validation of Acuros XB with Monte Carlo methods for photon dose calculations. Med Phys 2011; 38: Fogliata A, Nicolini G, Clivio A, Vanetti E, Mancosu P, Cozzi L. Dosimetric validation of Acuros XB Advanced Dose Calculation algorithm: fundamental characterization in water. Phys Med Biol 2011; 56: Ulmer W, Harder D. A triple gaussian pencil beam model for photon beam treatment planning. Z Med Phys 1995; 5: Ulmer W, Harder D. Applications of a triple gaussian pencil beam model for photon beam treatment planning. Z Med Phys 1996; 6: Tillikainen L, Helminen H, Torsti T, Siljamäki S, Alakuijala J, Pyyry J, Ulmer W. A 3D pencil-beam-based superposition algorithm for 268
9 Radiobiological Impact of Acuros XB Dose Calculation Algorithm on... photon dose calculation in heterogeneous media. Phys Med Biol 2008; 53: Tillikainen L, Siljamäki S, Helminen H, Alakuijala J, Pyyry J. Determination of parameters for a multiple-source model of megavoltage photon beams using optimization methods. Phys Med Biol 2007; 52: Gay HA, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med 2007; 23(3-4): Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002; 52: Oinam AS, Singh L, Shukla A, Ghoshal S, Kapoor R, Sharma SC. Dose volume histogram analysis and comparison of different radiobiological models using in-house developed software. J Med Phys 2011; 36: Qi XS, Semenenko VA, Li XA. Improved critical structure sparing with biologically based IMRT optimization. Med Phys 2009; 36(5): Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation doseresponse of human tumors. Int J Radiat Oncol Biol Phys 1995; 32(4): Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to lateresponding normal tissue. Int J Radiat Oncol Biol Phys 2002; 52(1): Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21(1): Burman C, Kutcher GJ, Emmai B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiation Oncology Biol Phys 1991; 21: Stewart FA, Randhawa VS, Michael BD. Multifraction irradiation of mouse bladders. Radiother Oncol 1984; 2(2): Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, Keane T, O Sullivan B, van Dyk J, Gupta N, et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys 1995; 33(3): Deore S M, Shrivastava S K, Supe S J, Viswanathan PS, Dinshaw KA. Alpha/beta value and importance of dose per fraction for the late rectal and recto-sigmoid complications. Strahlenther Onkol 1993; 169(9): Vlachaki MT, Teslow TN, Amosson C, Uy NW, Ahmad S. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization 2005; 30(2): Luxton, G, Hancock, SL, Boyer, AL. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2004; 59:
Radiobiological Impact of Planning Techniques for Prostate Cancer in Terms of Tumor Control Probability and Normal Tissue Complication Probability
Original Article Radiobiological Impact of Planning Techniques for Prostate Cancer in Terms of Tumor Control Probability and Normal Tissue Complication Probability Rana S, Cheng CY Department of Medical
More informationFeasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment
Chinese Journal of Cancer Original Article Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment Suresh Rana 1 and ChihYao Cheng 2 Abstract The volumetric modulated
More informationProstate volumetric-modulated arc therapy: dosimetry and radiobiological model variation between the single-arc and double-arc technique
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 3, 2013 Prostate volumetric-modulated arc therapy: dosimetry and radiobiological model variation between the single-arc and double-arc technique
More informationDosimetric Comparison: Acuros XB vs AAA
Dosimetric Comparison: Acuros XB vs AAA Leo El Hage, Chris James, Jim Frantzis, Roger Li, Venkata Sheshadri Epworth Radiation Oncology Epworth HealthCare Excellence. Everywhere. Everyday Background Epworth
More informationJOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 15, NUMBER 3, 2014
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 15, NUMBER 3, 2014 Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison
More informationDosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles
Baptist Health South Florida Scholarly Commons @ Baptist Health South Florida All Publications 2017 Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for
More information3-Dimensional conformal radiotherapy versus intensity modulated radiotherapy for localized prostate cancer: Dosimetric and radiobiologic analysis
Iran. J. Radiat. Res., 2007; 5 (1): 1-8 3-Dimensional conformal radiotherapy versus intensity modulated radiotherapy for localized prostate cancer: Dosimetric and radiobiologic analysis A.K. Bhardwaj 1*,T.S.
More informationThe performance of the progressive resolution optimizer (PRO) for RapidArc planning in targets with low-density media
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 6, 2013 The performance of the progressive resolution optimizer (PRO) for RapidArc planning in targets with low-density media Monica W.K.
More informationComparison of Anisotropic Analytic Algorithm Plan and Acuros XB Plan for Lung Stereotactic Ablative Radiotherapy Using Flattening Filter-Free Beams
Original Article PROGRESS in MEDICAL PHYSICS Vol. 25, No. 4, December, 2014 http://dx.doi.org/10.14316/pmp.2014.25.4.210 Comparison of Anisotropic Analytic Algorithm Plan and Acuros XB Plan for Lung Stereotactic
More informationA TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 394 400, 2014 A TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM * D. ADAM 1,2,
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationVerification of performance of Acuros XB Algorithm (AXB) Implemented on Eclipse Planning System
Original Article Research in Oncology 2018; Vol. 14, No. 1: 34-38. DOI: 10.21608/resoncol.2018.3026.1047 Verification of performance of Acuros XB Algorithm (AXB) Implemented on Eclipse Planning System
More informationA treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse
Peters et al. Radiation Oncology 2014, 9:153 RESEARCH Open Access A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse Samuel Peters
More informationA Dosimetric Comparison of Whole-Lung Treatment Techniques. in the Pediatric Population
A Dosimetric Comparison of Whole-Lung Treatment Techniques in the Pediatric Population Corresponding Author: Christina L. Bosarge, B.S., R.T. (R) (T) Indiana University School of Medicine Department of
More informationKnowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101. Cases from Duke Clinic. Deon Martina Dick
Knowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101 Cases from Duke Clinic by Deon Martina Dick Department of Medical Physics Duke University Date: Approved: Joseph Lo, Chair
More informationAssessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index
Original Article Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index Abdulhamid Chaikh, Jacques Balosso,2 Department of Radiation Oncology and Medical Physics,
More informationRapidArc vs Conventional IMRT for Head and Neck Cancer Irradiation: Is Faster Necessary Better?
DOI:10.22034/APJCP.2018.19.1.207 RESEARCH ARTICLE Editorial Process: Submission:10/05/2017 Acceptance:12/13/2017 RapidArc vs Conventional IMRT for Head and Neck Cancer Irradiation: Is Faster Necessary
More informationIMAT: intensity-modulated arc therapy
: intensity-modulated arc therapy M. Iori S. Maria Nuova Hospital, Medical Physics Department Reggio Emilia, Italy 1 Topics of the talk Rotational IMRT techniques: modalities & dedicated inverse-planning
More informationTaeryool Koo 1, Jin-Beom Chung 2*, Keun-Yong Eom 1,2, Jin-Yong Seok 2, In-Ah Kim 1,2 and Jae-Sung Kim 1,2
Koo et al. Radiation Oncology (2015) 10:48 DOI 10.1186/s13014-015-0346-3 RESEARCH Open Access Dosimetric effects of the acuros XB and anisotropic analytical algorithm on volumetric modulated arc therapy
More informationBaotian Huang 1, Lili Wu 1, Peixian Lin 2 and Chuangzhen Chen 1*
Huang et al. Radiation Oncology (2015) 10:53 DOI 10.1186/s13014-015-0357-0 RESEARCH Open Access Dose calculation of Acuros XB and Anisotropic Analytical Algorithm in lung stereotactic body radiotherapy
More informationStatistical Analysis and Volumetric Dose for Organ at Risk of Prostate Cancer
The African Review of Physics (2013) 8:0063 477 Statistical Analysis and Volumetric Dose for Organ at Risk of Prostate Cancer F. Assaoui¹,*, A. Bazine² and T. Kebdani³ ¹ Medical Physics Unit, Radiotherapy
More informationOriginal Article. Teyyiba Kanwal, Muhammad Khalid, Syed Ijaz Hussain Shah, Khawar Nadeem
Original Article Treatment Planning Evaluation of Sliding Window and Multiple Static Segments Technique in Intensity Modulated Radiotherapy for Different Beam Directions Teyyiba Kanwal, Muhammad Khalid,
More informationDosimetric evaluation of the Acuros XB algorithm for a 4 MV photon beam in head and neck intensity-modulated radiation therapy
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 4, 2015 Dosimetric evaluation of the Acuros XB algorithm for a 4 MV photon beam in head and neck intensity-modulated radiation therapy Kimiko
More informationTreatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI)
Treatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI) Tagreed AL-ALAWI Medical Physicist King Abdullah Medical City- Jeddah Aim 1. Simplify and standardize
More informationWHOLE-BRAIN RADIOTHERAPY WITH SIMULTANEOUS INTEGRATED BOOST TO MULTIPLE BRAIN METASTASES USING VOLUMETRIC MODULATED ARC THERAPY
doi:10.1016/j.ijrobp.2009.03.029 Int. J. Radiation Oncology Biol. Phys., Vol. 75, No. 1, pp. 253 259, 2009 Copyright Ó 2009 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/09/$ see front
More informationIntensity modulated radiotherapy (IMRT) for treatment of post-operative high grade glioma in the right parietal region of brain
1 Carol Boyd March Case Study March 11, 2013 Intensity modulated radiotherapy (IMRT) for treatment of post-operative high grade glioma in the right parietal region of brain History of Present Illness:
More informationThe bootstrap method to improve statistical analysis of dosimetric data for radiotherapy outcomes
The bootstrap method to improve statistical analysis of dosimetric data for radiotherapy outcomes Abdulhamid Chaikh1,2, Jean-Pierre Bresciani3,4, Jacques Balosso2,4 1Department of Radiation Oncology and
More informationA dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer
Foroudi et al. Radiation Oncology 2012, 7:111 RESEARCH Open Access A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer
More informationLeila E. A. Nichol Royal Surrey County Hospital
2 nd UK and Ireland Dosimetry Check User Meeting Symposium Clatterbridge Cancer Centre, 24 th October 2012 Leila E. A. Nichol Royal Surrey County Hospital Leila.Nichol@nhs.net *My experience with Dosimetry
More informationIMRT Planning Basics AAMD Student Webinar
IMRT Planning Basics AAMD Student Webinar March 12, 2014 Karen Chin Snyder, MS Senior Associate Physicist Department of Radiation Oncology Disclosures The presenter has received speaker honoraria from
More informationCommission, Ganakbari, Savar, Dhaka, Bangladesh
International Letters of Chemistry, Physics and Astronomy Submitted: 2016-05-17 ISSN: 2299-3843, Vol. 68, pp 54-60 Revised: 2016-07-08 doi:10.18052/www.scipress.com/ilcpa.68.54 Accepted: 2016-07-12 2016
More informationQuality assurance of volumetric modulated arc therapy using Elekta Synergy
Acta Oncologica, 2009; 48: 11931197 ORIGINAL ARTICLE Quality assurance of volumetric modulated arc therapy using Elekta Synergy AKIHIRO HAGA 1, KEIICHI NAKAGAWA 1, KENSHIRO SHIRAISHI 1, SAORI ITOH 1, ATSURO
More informationClinical Impact of Couch Top and Rails on IMRT and Arc Therapy
Texas Medical Center Library DigitalCommons@TMC UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences 8-2011 Clinical Impact of Couch Top and Rails on IMRT and Arc Therapy
More informationMonitor unit optimization in RapidArc plans for prostate cancer
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 3, 2013 Monitor unit optimization in RapidArc plans for prostate cancer Stefania Clemente, 1a Mariella Cozzolino, 1 Costanza Chiumento, 2
More informationTreatment plan comparison of Linac step and shoot, Tomotherapy, RapidArc, and Proton therapy for prostate
Treatment plan comparison of Linac step and shoot, Tomotherapy, RapidArc, and Proton therapy for prostate cancer using dosimetrical and biological index Suk Lee, Yuan Jie Cao, Kyung Hwan Chang, Jang Bo
More informationQuality Assurance of TPS: comparison of dose calculation for stereotactic patients in Eclipse and iplan RT Dose
Petrovic B Comparison of dose calculation algorithms for stereotaxy Quality Assurance of TPS: comparison of dose calculation for stereotactic patients in and RT Dose Borislava Petrovic 1, Aleksandra Grządziel
More informationMeasurement of Dose to Critical Structures Surrounding the Prostate from. Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation Therapy (3D-CRT); A Comparative Study Erik
More informationSanja Ognjenovic A PROJECT. submitted to. Oregon State University. University Honors College
Volumetric-modulated arc radiotherapy for pancreatic malignancies: Dosimetric comparison with helical TomoTherapy By Sanja Ognjenovic A PROJECT submitted to Oregon State University University Honors College
More informationRadiation Damage Comparison between Intensity Modulated Radiotherapy (IMRT) and Field-in-field (FIF) Technique In Breast Cancer Treatments
Radiation Damage Comparison between Intensity Modulated Radiotherapy () and Field-in-field (FIF) Technique In Breast Cancer Treatments Huisi Ai 1 and Hualin Zhang 2 1. Department of Radiation Oncology,
More informationTreatment of exceptionally large prostate cancer patients with low-energy intensity-modulated photons
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 4, FALL 2006 Treatment of exceptionally large prostate cancer patients with low-energy intensity-modulated photons Mei Sun and Lijun Ma a University
More informationA Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer
A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer Tony Kin Ming Lam Radiation Planner Dr Patricia Lindsay, Radiation Physicist Dr John Kim, Radiation Oncologist Dr Kim Ann Ung,
More informationEvaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy
Evaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy Rungdham Takam Thesis submitted for the degree of Doctor of Philosophy in The School of Chemistry
More informationOPTIMIZATION OF COLLIMATOR PARAMETERS TO REDUCE RECTAL DOSE IN INTENSITY-MODULATED PROSTATE TREATMENT PLANNING
Medical Dosimetry, Vol. 30, No. 4, pp. 205-212, 2005 Copyright 2005 American Association of Medical Dosimetrists Printed in the USA. All rights reserved 0958-3947/05/$ see front matter doi:10.1016/j.meddos.2005.06.002
More informationEvaluation of the Dynamic Arc-Therapy in Comparison to Conformal Radiation Therapy in Radiotherapy Patients
Evaluation of the Dynamic Arc-Therapy in Comparison to Conformal Radiation Therapy in Radiotherapy Patients Aliaa Mahmoud (1,4), Ehab M. Attalla (2,3), M..S. El-Nagdy (4), Gihan Kamel (4) (1) Radiation
More informationEvaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer
1 Charles Poole April Case Study April 30, 2012 Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer Abstract: Introduction: This study
More informationApplication of asi-kvcbct for Volume Assessment and Dose Estimation: An Offline Adaptive Study for Prostate Radiotherapy
DOI:10.31557/APJCP.2019.20.1.229 Volume and Dose Assessment on Adapted CT RESEARCH ARTICLE Editorial Process: Submission:08/10/2018 Acceptance:01/05/2019 Application of asi-kvcbct for Volume Assessment
More informationAdvanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark*
Advanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark* Purpose: To evaluate an institution s 3D treatment planning process and the institution
More informationEvaluation of Three-dimensional Conformal Radiotherapy and Intensity Modulated Radiotherapy Techniques in High-Grade Gliomas
1 Carol Boyd Comprehensive Case Study July 11, 2013 Evaluation of Three-dimensional Conformal Radiotherapy and Intensity Modulated Radiotherapy Techniques in High-Grade Gliomas Abstract: Introduction:
More informationRectal dose and toxicity dosimetric evaluation for various beam arrangements using pencil beam scanning protons with and without rectal spacers
Rectal dose and toxicity dosimetric evaluation for various beam arrangements using pencil beam scanning protons with and without rectal spacers 2015 MAC-AAPM Annual Meeting, Baltimore, MD Heeteak Chung,
More informationVMAT planning study in rectal cancer patients
Shang et al. Radiation Oncology 2014, 9:219 RESEARCH Open Access VMAT planning study in rectal cancer patients Jun Shang, Wei Kong, Yan-yang Wang *, Zhe Ding, Gang Yan and Hong Zhe Abstract Background:
More informationClinical Implications of High Definition Multileaf Collimator (HDMLC) Dosimetric Leaf Gap (DLG) Variations
Original Article PROGRESS in MEDICAL PHYSICS 27(3), Sept. 2016 http://dx.doi.org/10.14316/pmp.2016.27.3.111 pissn 2508-4445, eissn 2508-4453 Clinical Implications of High Definition Multileaf Collimator
More informationDosimetric consequences of tumor volume changes after kilovoltage cone-beam computed tomography for non-operative lung cancer during adaptive
Oncology and Translational Medicine October 2015, Vol. 1, No. 5, P195 200 DOI 10.1007/s10330-015-0054-3 ORIGINAL ARTICLE Dosimetric consequences of tumor volume changes after kilovoltage cone-beam computed
More informationWill CyberKnife M6 Multileaf collimator offer advantages over IRIS collimator in prostate SBRT?
Will CyberKnife M6 Multileaf collimator offer advantages over collimator in prostate SBRT? Vindu Kathriarachchi Professional Science Master in Medical Physics Department of Physics, Florida Atlantic University,
More informationIntroduction of RapidArc TM : an example of commissioning and implementing a QA programme for a new technology
Introduction of RapidArc TM : an example of commissioning and implementing a QA programme for a new technology Philip Mayles Clatterbridge Centre for Oncology, Wirral, UK 1 What is RapidArc (or VMAT)?
More informationComparison of VMAT-SABR treatment plans with flattening filter (FF) and flattening filter-free (FFF) beam for localized prostate cancer
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 6, 2015 Comparison of VMAT-SABR treatment plans with flattening filter (FF) and flattening filter-free (FFF) beam for localized prostate cancer
More informationRanking radiotherapy treatment plans: physical or biological objectives?
Ranking radiotherapy treatment plans: physical or biological objectives? Martin Ebert Department of Radiation Oncology, Sir Charles Gairdner Hospital, Western Australia, Australia Background. The ranking
More informationDosimetric Analysis of Respiratory-Gated RapidArc with Varying Gating Window Times
Original Article PROGRESS in MEDICAL PHYSICS Vol. 26, No. 2, June, 2015 http://dx.doi.org/10.14316/pmp.2015.26.2.87 Dosimetric Analysis of Respiratory-Gated RapidArc with Varying Gating Window Times Mee
More informationThis article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution
More informationHelical tomotherapy for head and neck squamous cell carcinoma: Dosimetric comparison with linear accelerator-based step-and-shoot IMRT
Original Article Free full text available from www.cancerjournal.net Helical tomotherapy for head and neck squamous cell carcinoma: Dosimetric comparison with linear accelerator-based step-and-shoot IMRT
More informationTHE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS
THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS ICTP SCHOOL ON MEDICAL PHYSICS FOR RADIATION THERAPY DOSIMETRY AND TREATMENT PLANNING FOR BASIC AND ADVANCED APPLICATIONS March
More informationVaginal Sparing with Volumetric Modulated Arc Therapy (VMAT) for Rectal Cancer. Scott Boulet BSc, RT(T)
Vaginal Sparing with Volumetric Modulated Arc Therapy (VMAT) for Rectal Cancer Scott Boulet BSc, RT(T) Outline Background Objectives Design Results Discussion Conclusion Acknowledgements Questions Background
More informationJOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 4, 2015
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 4, 2015 Dosimetric comparison of Acuros XB with collapsed cone convolution/superposition and anisotropic analytic algorithm for stereotactic
More informationA VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 401 410, 2014 A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM * M. D. SUDITU 1,2, D. ADAM 1,2, R. POPA 1,2, V. CIOCALTEI
More informationVolumetric Modulated Arc Therapy in a Large Body Habitus Patient with Left Breast Cancer: A Dosimetric Study
imedpub Journals http://www.imedpub.com Archives Archives in Cancer in Cancer Research Research ISSN 2254-681 Abstract Volumetric Modulated Arc Therapy in a Large Body Habitus Patient with Left Breast
More informationComparing conformal, arc radiotherapy and helical tomotherapy in craniospinal irradiation planning
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 15, NUMBER 5, 2014 Comparing conformal, arc radiotherapy and helical tomotherapy in craniospinal irradiation planning Pamela A. Myers, 1 Panayiotis Mavroidis,
More informationDepartment of Medical Physics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Department of Radiation Oncology,
Technology in Cancer Research and Treatment ISSN 1533-0346 Volume 11, Number 3, June 2012 Adenine Press (2012) Single Arc Volumetric Modulated Arc Therapy for Complex Brain Gliomas: Is There an Advantage
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationIMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia
IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes
More informationSilvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida
American Association of Medical Dosimetrists 2015 Silvia Pella, PhD, DABR Brian Doozan, MS South Florida Radiation Oncology Florida Atlantic University Advanced Radiation Physics Boca Raton, Florida Most
More informationThe Physics of Oesophageal Cancer Radiotherapy
The Physics of Oesophageal Cancer Radiotherapy Dr. Philip Wai Radiotherapy Physics Royal Marsden Hospital 1 Contents Brief clinical introduction Imaging and Target definition Dose prescription & patient
More informationDosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 15, NUMBER 3, 2014 Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an
More informationEvaluation of Dynamic Delivery Quality Assurance Process for Internal Target Volume Based RapidArc
Original Article PMP Progress in Medical Physics 28(4), December 217 https://doi.org/1.14316/pmp.217.28.4.181 pissn 258-4445, eissn 258-4453 Evaluation of Dynamic Delivery Quality Assurance Process for
More informationIn-silico study to compare proton versus photon radiotherapy: a modelization based decision protocol ProtonShare Project
In-silico study to compare proton versus photon radiotherapy: a modelization based decision protocol ProtonShare Project Abdulhamid Chaikh, Jacques Balosso Department of Radiation Oncology and Medical
More information162 Popescu et al.: Couch gantry arc in partial breast 162
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 1, 2013 Simultaneous couch and gantry dynamic arc rotation (CG-Darc) in the treatment of breast cancer with accelerated partial breast irradiation
More informationOptimal collimator rotation based on the outline of multiple brain targets in VMAT
Kim et al. Radiation Oncology (2018) 13:88 https://doi.org/10.1186/s13014-018-1039-5 RESEARCH Optimal collimator rotation based on the outline of multiple brain targets in VMAT Jung-in Kim 1,2,3, Beom
More informationIs there a preferred IMRT technique for left-breast irradiation?
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 3, 2015 Is there a preferred IMRT technique for left-breast irradiation? Marloes Jeulink, a Max Dahele, Philip Meijnen, Ben J. Slotman, Wilko
More informationNormal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT
Received: 28 September 2017 Revised: 17 November 2017 Accepted: 28 December 2017 DOI: 10.1002/acm2.12276 RADIATION ONCOLOGY PHYSICS Normal tissue doses from MV image-guided radiation therapy (IGRT) using
More informationVMAT plans for treatment prostate cancer: Dosimetric verifications and comparison with 3D-CRT and IMRT
VMAT plans for treatment prostate cancer: Dosimetric verifications and comparison with 3D-CRT and IMRT Poster No.: C-0520 Congress: ECR 2011 Type: Scientific Exhibit Authors: Y. Kawasaki, S. Tadokoro,
More informationEvaluation of volumetric modulated arc therapy for postmastectomy treatment
Nichols et al. Radiation Oncology 2014, 9:66 RESEARCH Open Access Evaluation of volumetric modulated arc therapy for postmastectomy treatment Geoffrey P Nichols 1, Jonas D Fontenot 1,2*, John P Gibbons
More informationCRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 5, 2013 CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer Xiance Jin, Jinling Yi, Yongqiang Zhou,
More informationNormal tissue dose in pediatric VMAT Piotr Zygmanski
Normal tissue dose in pediatric VMAT Piotr Zygmanski Department of Radiation Oncology Brigham and Women s Hospital Radiation induced effects in children Risk of inducing 2 nd cancers higher than for adults
More informationVolumetric-modulated arc therapy vs c-imrt in esophageal cancer: A treatment planning comparison
Online Submissions: http://www.wjgnet.com/esps/ wjg@wjgnet.com doi:10.3748/wjg.v18.i37.5266 World J Gastroenterol 2012 October 7; 18(37): 5266-5275 ISSN 1007-9327 (print) ISSN 2219-2840 (online) 2012 Baishideng.
More informationEditorial Process: Submission:11/14/2017 Acceptance:07/31/2018
DOI:10.22034/APJCP.2018.19.9.2499 Dosimetric Comparison of SIB IMRT vs SIB VMAT in Gliomas RESEARCH ARTICLE Editorial Process: Submission:11/14/2017 Acceptance:07/31/2018 Dosimetric Comparison and Feasibility
More informationEvaluation of target dose inhomogeneity in breast cancer treatment due to tissue elemental differences
Fogliata et al. Radiation Oncology (2018) 13:92 https://doi.org/10.1186/s13014-018-1022-1 RESEARCH Open Access Evaluation of target dose inhomogeneity in breast cancer treatment due to tissue elemental
More informationDosimetric Comparison of Intensity-Modulated Radiotherapy versus 3D Conformal Radiotherapy in Patients with Head and Neck Cancer
Dosimetric Comparison of Intensity-Modulated Radiotherapy versus 3D Conformal Radiotherapy in Patients with Head and Neck Cancer 1- Doaa M. AL Zayat. Ph.D of medical physics, Ayadi-Al Mostakbl Oncology
More informationJOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 6, NUMBER 2, SPRING 2005
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 6, NUMBER 2, SPRING 2005 Advantages of inflatable multichannel endorectal applicator in the neo-adjuvant treatment of patients with locally advanced
More informationChapters from Clinical Oncology
Chapters from Clinical Oncology Lecture notes University of Szeged Faculty of Medicine Department of Oncotherapy 2012. 1 RADIOTHERAPY Technical aspects Dr. Elemér Szil Introduction There are three possibilities
More informationONCOLOGY LETTERS 11: , 2016
ONCOLOGY LETTERS 11: 959-964, 2016 A comparative dosimetric study of volumetric modulated arc therapy vs. fixed field intensity modulated radiotherapy in postoperative irradiation of stage IB IIA high
More informationGuidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy
Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy VERSION 2.1 April 2015 Table of Contents Abbreviations & Glossary... 3 Executive Summary...
More informationEfficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO
Investigations and research Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO M. Kunze-Busch P. van Kollenburg Department of Radiation Oncology, Radboud University Nijmegen Medical
More informationRelationship of segment area and monitor unit efficiency in aperture-based IMRT optimization
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 3, 2013 Relationship of segment area and monitor unit efficiency in aperture-based IMRT optimization Peng Qi and Ping Xia a Department of
More informationDosimetry of conformal dynamic arc radiotherapy and intensity modulated radiotherapy in unresectable cholangiocarcinoma
Asian Biomedicine Vol. 4 No. 1 February 2010; 131-139 Technical report Dosimetry of conformal dynamic arc radiotherapy and intensity modulated radiotherapy in unresectable cholangiocarcinoma Thanarpan
More informationRESEARCH ARTICLE. Aydin Cakir 1, Zuleyha Akgun 2 *, Merdan Fayda 1, Fulya Agaoglu 1. Abstract. Introduction
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.8.3365 3-D Conformal, Intensity Modulated and Volumetric Modulated Arc Radiation Therapies for Low Radiation Exposure RESEARCH ARTICLE Comparison of Three Dimensional
More informationEffect of bladder filling on doses to prostate and organs at risk: a treatment planning study
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 8, NUMBER 1, WINTER 2007 Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study Vitali Moiseenko, 1 Mitchell Liu,
More informationA comparative dosimetric analysis of the effect of heterogeneity corrections used in three treatment planning algorithms
The University of Toledo The University of Toledo Digital Repository Theses and Dissertations 2010 A comparative dosimetric analysis of the effect of heterogeneity corrections used in three treatment planning
More informationResults of a 10-year survey of workload for 10 treatment vaults at a high-throughput comprehensive cancer center
Received: 17 August 2016 Revised: 18 November 2016 Accepted: 15 February 2017 DOI: 10.1002/acm2.12076 RADIATION PROTECTION & REGULATIONS Results of a 10-year survey of workload for 10 treatment vaults
More informationLinac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR
Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR PhD, FAAPM, FACR, FASTRO Department of Radiation Oncology Indiana University School of Medicine Indianapolis, IN, USA Indra J. Das,
More informationJOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 6, 2016
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 6, 2016 Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily
More informationA dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 1, 2013 A dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer Caitlin E. Merrow, a Iris Z. Wang, Matthew B. Podgorsak
More information